Want to join the conversation?
$IPAR's 2Q16 net sales grew 14.8% to $117.2MM, driven by sales growth in Montblanc, Jimmy Choo and Rochas brands. Geographically, Western Europe and North America sales grew 44.6% and 10.5%, respectively. Overall sales in Asia are slightly ahead of 1H of 2016 despite negative market conditions in China.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.